Abstract
Cherry fruit (Prunusavium) is a rich source of bioactive compounds, including polyphenols, flavonoids, and anthocyanins. These compounds have been reported to possess various health benefits, including antioxidant, anti-inflammatory, and antimicrobial activities. This study aimed to conduct a comprehensive phytochemical screening of cherry fruit to identify and quantify its bioactive compounds. Cherry fruit samples were extracted using various solvents, including methanol, ethanol, and water. The extracts were then analyzed using various phytochemical screening techniques, including high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), and nuclear magnetic resonance (NMR) spectroscopy. The results of the phytochemical screening revealed the presence of various bioactive compounds in cherry fruit, including anthocyanins, flavonoids, phenolic acids, and terpenoids. The major anthocyanin present in cherry fruit was identified as cyanidin-3-glucoside. The total phenolic content of cherry fruit was found to be 354.5 mg gallic acid equivalents (GAE)/100g. This study provides a comprehensive analysis of the phytochemical composition of cherry fruit. The results of this study suggest that cherry fruit is a rich source of bioactive compounds, which may contribute to its potential health benefits. Further studies are needed to fully explore the therapeutic potential of cherry fruit and its bioactive compounds.